X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him

By Holly Campbell  |    October 30, 2014
When Matt Ellefson developed a cough, he didn’t think much of it.  He just assumed it was caused by the cold winter air, but as the weeks passed by his cough lingered. Then he began coughing up...   Read More

Second-Guessing Your Doctor: Possible Barriers to Access

By Allyson Funk  |    October 29, 2014
When selecting health insurance coverage to suit you and your family’s needs, you may think it is safe to assume your plan will help cover the medicines prescribed by your doctor. This, however,...   Read More

Access to Combination Therapies May Be Limited with Exchange Coverage

By Allyson Funk  |    October 23, 2014
Would you rather take three different pills a day, following specific instructions for each, making sure you don’t forget one or just one pill a day that has the same effect? As drug development...   Read More

Disparities in Health Coverage: Not All Services Are Created Equal

By Allyson Funk  |    October 22, 2014
When it comes to health coverage, access to health care services is not always the same. For some, out-of-pocket costs may create barriers to access and hinder adherence to needed services and...   Read More

I'm Not Average: Marina Is Living Well in Spite of Stomach Cancer

By Holly Campbell  |    October 21, 2014
When Marina Symcox was diagnosed with gastrointestinal stromal tumor (GIST) she was given no hope. In the late 1990’s, there were no effective treatments for GIST - a rare and very deadly type of...   Read More

ICYMI – NYT: Unable to Meet the Deductible or the Doctor

By Allyson Funk  |    October 20, 2014
In case you missed it, a front-page story in The New York Times this weekend told the story of Patricia Wanderlich and several other patients who, despite purchasing coverage through the health...   Read More

Collaboration Between PhRMA and Scientific American Highlights Biomedical Science

By Bill Chin, M.D.  |    October 20, 2014
Scientific progress is complex, time-consuming and expensive. Researchers continue to broaden our collective understanding of disease with the hope that new findings will lead to advancements that...   Read More

Week in Review: Access, Patients, Part D, Oh My

By PhRMA Staff  |    October 17, 2014
Thanks in large part to innovative new treatments, now more than ever, patients can live longer, healthier lives. But in order for this to be possible, access to needed medicines is critical.   Read More

Five Things You Might Not Know About Medicare Part D

By Allyson Funk  |    October 15, 2014
Another Medicare open enrollment period begins today, Wednesday, October 15, and runs through Sunday, December 7. During open enrollment seniors and individuals with disabilities can evaluate...   Read More

The ABCs of Health Coverage

By Allyson Funk  |    October 14, 2014
  Insurance jargon can be confusing. Whether you’ve been choosing a health plan annually for years or have coverage for the first time, it can be tricky to figure out exactly what your plan covers...   Read More

I'm Not Average: 13 Years Later, Jamie Is Still Here

By Holly Campbell  |    October 10, 2014
Jamie Pires fainted in her doctor’s office when she was told she has Chronic Myelogenous Leukemia (CML), a cancer the starts inside the bone marrow. This wasn’t supposed to happen. Even her doctor...   Read More

We Must Work Together to Lessen the Toll of Mental Illness

By Guest Contributor  |    October 8, 2014
Mental Illness Awareness Week, which takes place the first full week of October, is an opportunity to raise awareness of mental illness and make progress in eliminating stigmas that discourage...   Read More

New Report Shows Past Drug Failures Aid in the Fight Against Cancer

By John Castellani  |    October 8, 2014
This week PhRMA released a new report, “Researching Cancer Medicines: Setbacks and Stepping Stones,” which examines the investigational cancer medicines that did not succeed in clinical trials and...   Read More

ICYMI: Debunking Myths about Cancer Care in the United States

By Holly Campbell  |    October 7, 2014
Cancer is a devastating diagnosis and it’s hard to find someone who hasn’t been touched by the disease.  However, given its complexity, the facts about cancer care are often misconstrued. A new ...   Read More

Why Are Cancer Medicines Expensive?

By John Castellani  |    October 6, 2014
This post first appeared on the Morning Consult.  Prescription medicines account for just nine cents of every dollar spent on health care in the U.S., and cancer medicines represent just one percent...   Read More

What 60 Minutes Missed on the Value and Cost of Cancer Medicines

By Josephine Martin  |    October 5, 2014
The biopharmaceutical industry is proud of its track record of developing innovative medicines that have extended and improved the lives of patients suffering from cancer.   Read More

I’m Not Average Campaign Hits Close to Home

By Holly Campbell  |    October 4, 2014
My grandmother, better known as Mema, passed away from lung cancer nearly four years ago on December 19, 2010. Exactly 24 hours after my birthday.     Read More

Our Commitment to Turning the Tide Against Cancer

By Randy Burkholder  |    October 3, 2014
Can we meet the challenge of accelerating progress against cancer in an era of increasing pressure for cost containment? At PhRMA we believe the answer is yes; we recognize it won’t be easy; and we...   Read More

Empowering Patients to Be Active Participants in Clinical Trials

By Stephanie Fischer  |    October 2, 2014
One of the topics of discussion at the recent Rare Patient Advocacy Summit hosted by Global Genes was the role of patients in healthcare.  A statement that clearly resonated with the audience,...   Read More

When It Comes to Getting Your Meds, Are You Covered?

By Allyson Funk  |    October 1, 2014
Four in five American adults take at least one medication, and more than one in four take five medicines or more. For patients to live longer, healthier lives, being able to access needed...   Read More

What They Are Saying About Patients’ Access to Medicines

By Robert Zirkelbach  |    October 1, 2014
Helping to ensure patients have access to the medicines they need is a top priority for the biopharmaceutical industry. Over the past 15 years, biopharmaceutical companies have had more than 400 new...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates